Hirano Katsuya, Hirano Mayumi, Kanaide Hideo
Division of Molecular Cardiology, Research Institute of Angiocardiology, Graduate School of Medical Sciences, Kyushu University, Higashi-ku, Fukuoka 812-8582, Japan.
J Smooth Muscle Res. 2004 Dec;40(6):219-36. doi: 10.1540/jsmr.40.219.
The Ca2+-dependent, reversible phosphorylation of the 20 kDa regulatory myosin light chain (MLC) plays a primary role in regulating the contraction of smooth muscle. However, it is well known that the Ca2+ signal is not the only factor which regulates such contraction, however, the alteration of the Ca2+ sensitivity in the contractile apparatus is also known to play an important role. The degree of MLC phosphorylation is determined by the balance of the activity between phosphorylation and dephosphorylation. Either the Ca2+-independent activation of MLC phosphorylation or the inhibition of MLC dephosphorylation causes a greater MLC phosphorylation for a given level of Ca2+ signal and thereby potentiates the myofilament Ca2+ sensitivity. The smooth muscle myosin light chain phosphatase (MLCP) consisting of three subunits was first isolated and cloned in the early '90s. The intensive investigation thereafter has uncovered the biochemical basis for regulating the activity of MLCP. The regulation of the MLCP activity is now considered to play a critical role in regulating the myofilament Ca2+ sensitivity. There are three major mechanisms in the regulation of MLCP; (1) the phosphorylation of a 110 kDa regulatory subunit of MLCP (2) the conformational change of the trimeric structure, and (3) the inhibition by a smooth muscle specific inhibitor protein, CPI-17. Furthermore, some kinases have been found to phosphorylate the MLC and activate the contraction of smooth muscle in a Ca2+-independent manner. Numerous protein kinases have been found to be involved in the regulation of MLC phosphorylation, and rho-kinase is one of the most frequently investigated kinases. The smooth muscle physiology is now asked to integrate the current understanding of the biochemical mechanisms and to clarify which kinases and/or proteins in the contractile apparatus play a physiological role in regulating the myofilament Ca2+ sensitivity and how such extracellular contractile stimulation modulates these mechanisms.
20 kDa 调节型肌球蛋白轻链(MLC)的钙离子依赖性可逆磷酸化在调节平滑肌收缩中起主要作用。然而,众所周知,钙离子信号并非调节此类收缩的唯一因素,收缩装置中钙离子敏感性的改变也起着重要作用。MLC 的磷酸化程度由磷酸化和去磷酸化之间的活性平衡决定。MLC 磷酸化的钙离子非依赖性激活或 MLC 去磷酸化的抑制,在给定钙离子信号水平下会导致更大程度的 MLC 磷酸化,从而增强肌丝的钙离子敏感性。由三个亚基组成的平滑肌肌球蛋白轻链磷酸酶(MLCP)于 20 世纪 90 年代初首次被分离和克隆。此后的深入研究揭示了调节 MLCP 活性的生化基础。目前认为,MLCP 活性的调节在调节肌丝钙离子敏感性中起关键作用。MLCP 的调节有三种主要机制:(1)MLCP 的 110 kDa 调节亚基的磷酸化;(2)三聚体结构的构象变化;(3)平滑肌特异性抑制蛋白 CPI-17 的抑制作用。此外,还发现一些激酶可使 MLC 磷酸化并以钙离子非依赖性方式激活平滑肌收缩。已发现众多蛋白激酶参与 MLC 磷酸化的调节,而 Rho 激酶是研究最频繁的激酶之一。目前需要平滑肌生理学整合对生化机制的当前理解,以阐明收缩装置中的哪些激酶和/或蛋白质在调节肌丝钙离子敏感性中发挥生理作用,以及这种细胞外收缩刺激如何调节这些机制。